Deals17 Feb 2025, 07:47 pm
Sun Pharma Amongst Top 5% Of Global Pharmaceutical Companies In S&P Global Sustainability Yearbook 2025
AI Summary
Sun Pharmaceutical Industries Limited has been included in the S&P Global Sustainability Yearbook 2025, qualifying in the Top 5% of pharmaceutical companies assessed by S&P globally. This recognition is a testament to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses. The S&P Global Corporate Sustainability Assessment (CSA) for 2024 assessed over 7,690 companies globally, out of which 780 qualified for inclusion in The Sustainability Yearbook 2025.
Key Highlights
- Sun Pharma Amongst Top 5% Of Global Pharmaceutical Companies In S&P Global Sustainability Yearbook 2025
- Inclusion in the Yearbook is based on the S&P Global Corporate Sustainability Assessment (CSA) for 2024
- Sun Pharma qualified in the Top 5% of pharmaceutical companies assessed by S&P globally
- Recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles
- 780 companies qualified for inclusion in The Sustainability Yearbook 2025 globally